The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
WHO's new End TB Strategy
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The first quantitative milestones in the End TB Strategy called for a 35% reduction in deaths due to tuberculosis and a 20% reduction in the tuberculosis incidence rate by 2020.5”
In the citing paper
“The WHO End TB Strategy represents a renewed global resolve to accelerate progress by aiming to reduce deaths due to tuberculosis by 95% and cut tuberculosis incidence by 90% between 2015 and 2035, while also seeking to have zero tuberculosis-affected households experiencing catastrophic financial costs due to the disease by 2035.5”
Citations
Cites
Tuberculosis control and elimination 2010–50: cure, care, and social development
Lönnroth, K., Castro, K. G., Chakaya, J. M., Chauhan, L. S., Floyd, K., Glaziou, P., & Raviglione, M. C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60483-7 · Cited by 899
Self-citationMDR Tuberculosis — Critical Steps for Prevention and Control
Nathanson, E., Nunn, P., Uplekar, M., Floyd, K., Jaramillo, E., Lönnroth, K., Weil, D., & Raviglione, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0908076 · Cited by 189
Self-citationLönnroth, K., Glaziou, P., Weil, D. E. C., Floyd, K., Uplekar, M. W., & Raviglione, M. C. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001693 · Cited by 141
Self-citationFloyd, K., Fitzpatrick, C., Pantoja, A., & Raviglione, M. C. (2013) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70032-9 · Cited by 47
Self-citationSetting new targets in the fight against tuberculosis
Raviglione, M. C., & Diţiu, L. (2013) · Nature Medicine · doi:10.1038/nm.3129 · Cited by 28
Self-citationToward Tuberculosis Elimination in Low-Incidence Countries: Reflections From a Global Consultation
Lönnroth, K., Migliori, G. B., & Raviglione, M. C. (2014) · Annals of Internal Medicine · doi:10.7326/m14-1888 · Cited by 13
Self-citationRebalancing the global battle against tuberculosis
Raviglione, M. C., Uplekar, M., Vincent, C., & Pablos-Méndez, A. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70166-9 · Cited by 9
Self-citation
Cited by
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
Houben, R. M. G. J., & Dodd, P. J. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002152 · Cited by 2,054
Pai, M., Behr, M. A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C. C., Ginsberg, A., Swaminathan, S., Spigelman, M., Getahun, H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.76 · Cited by 1,270
Self-citationDorman, S. E., Schumacher, S. G., Alland, D., Nabeta, P., Armstrong, D. T., King, B., Hall, S. L., Chakravorty, S., Cirillo, D. M., Tukvadze, N., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30691-6 · Cited by 689
Getahun, H., Matteelli, A., Abubakar, I., Aziz, M. A., Baddeley, A., Barreira, D., Den Boon, S., Borroto Gutierrez, S. M., Bruchfeld, J., Burhan, E., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01245-2015 · Cited by 596
Self-citationDrain, P. K., Bajema, K. L., Dowdy, D., Dheda, K., Naidoo, K., Schumacher, S. G., Ma, S., Meermeier, E., Lewinsohn, D. M., & Sherman, D. R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00021-18 · Cited by 565
Metadata
- Authors
- Uplekar, M., Weil, D., Lonnroth, K., Jaramillo, E., Lienhardt, C., Dias, H. M., Falzon, D., Floyd, K., Gargioni, G., Getahun, H., Gilpin, C., Glaziou, P., Grzemska, M., Mirzayev, F., Nakatani, H., & Raviglione, M.
- Affiliations
- World Health Organization (CH)
- Corresponding author
- Uplekar, Mukund
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 385
- Issue
- 9979
- Pages
- 1799-1801
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2133928209
- Cited by
- 1,117
- References
- 7
- Citations by year
- 2026: 82 · 2025: 94 · 2024: 88 · 2023: 116 · 2022: 104 · 2021: 124 · 2020: 128 · 2019: 119 · 2018: 87 · 2017: 81 · 2016: 68 · 2015: 25
- FWCI
- 68.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- End TB Strategy, tuberculosis, World Health Organization, global health strategy, tuberculosis prevention, tuberculosis care, tuberculosis control, World Health Assembly
- MeSH terms
- Humans, Tuberculosis, World Health Organization, Early Diagnosis, Disease Eradication, Early Medical Intervention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: WHO's new End TB Strategy. https://app.cochat.ai/papers/10.1016/s0140-6736(15)60570-0
- The paper
- Uplekar, M., Weil, D., Lonnroth, K., Jaramillo, E., Lienhardt, C., Dias, H. M., Falzon, D., Floyd, K., Gargioni, G., Getahun, H., Gilpin, C., Glaziou, P., Grzemska, M., Mirzayev, F., Nakatani, H., & Raviglione, M. (2015). WHO's new End TB Strategy. The Lancet. https://doi.org/10.1016/s0140-6736(15)60570-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.